Division of Cardiology, Mitsui Memorial Hospital, Tokyo, Japan.
Department of Cardiology, Tokai University School of Medicine, Kanagawa, Japan.
J Cardiol. 2019 Nov;74(5):436-442. doi: 10.1016/j.jjcc.2019.04.011. Epub 2019 Jun 24.
In-stent restenosis (ISR) remains a problematic issue of coronary intervention. The non-slip element balloon (NSE) is a balloon catheter with 3 longitudinal nylon elements which are attached proximally and distally to the balloon component. The expectation is that this design of balloon is able to achieve a larger lumen area due to the elements, as well as reducing balloon slippage. We investigated whether NSE pre-dilatation improves angiographic outcomes compared to a high pressure non-compliant balloon pre-dilatation, followed by a drug-coating balloon (DCB) for treatment of ISR lesions with optical coherence tomographic imaging (OCT).
Patients were eligible for the study if one or more in-stent restenosis lesions were treated with a paclitaxel-coating balloon. Patients were randomized to NSE pre-dilatation (NSE group) or high pressure non-compliant balloon pre-dilatation (POBA group) in a 1:1 fashion in 17 hospitals. The primary endpoint was in-segment late loss [post minimal lumen diameter (MLD)-follow-up MLD] at 8 months.
One hundred and five patients were allocated to each group. Balloon slippage (7.9% versus 22.9%, p=0.002) and geographical miss (6.9% versus 21.9%, p=0.002) were observed less in the NSE group compared to the POBA group. Acute gain was significantly larger in the NSE group (1.17±0.42mm versus 1.06±0.35mm, p=0.04), but post minimum stent lumen area analyzed by OCT was similar between the two groups (3.85±1.67mm versus 3.81±1.93mm, p=0.64). At 8 months, average lesion length was significantly shorter than the POBA group (5.78±3.26mm versus 6.97±4.59mm, p=0.04), but average in-segment late loss was similar between the two groups (0.28±0.45mm versus 0.27±0.38mm, p=0.75).
Eight-month angiographic outcomes were similar between NSE and non-compliant balloon pre-dilatation with DCB for treatment of ISR lesions. However, NSE pre-dilatation has advantages such as reduction of balloon slippage and geographical miss during the procedure.
支架内再狭窄(ISR)仍然是冠状动脉介入治疗的一个有问题的问题。非滑元件球囊(NSE)是一种带有 3 个纵向尼龙元件的球囊导管,这些元件近端和远端附着在球囊组件上。期望这种设计的球囊能够由于元件而实现更大的管腔面积,并减少球囊滑脱。我们研究了 NSE 预扩张是否比高压顺应性差的球囊预扩张在治疗 ISR 病变时更能改善血管造影结果,然后使用药物涂层球囊(DCB)进行治疗,同时使用光学相干断层扫描成像(OCT)。
如果一个或多个支架内再狭窄病变用紫杉醇涂层球囊治疗,患者即有资格参加这项研究。在 17 家医院中,以 1:1 的比例将患者随机分为 NSE 预扩张(NSE 组)或高压顺应性差的球囊预扩张(POBA 组)。主要终点是 8 个月时的节段内晚期丢失[随访最小管腔直径(MLD)后的 MLD]。
每组有 105 名患者被分配到各自的组中。与 POBA 组相比,NSE 组的球囊滑脱(7.9%比 22.9%,p=0.002)和地理缺失(6.9%比 21.9%,p=0.002)较少。NSE 组的急性获得明显更大(1.17±0.42mm 比 1.06±0.35mm,p=0.04),但两组 OCT 分析的支架内最小管腔面积相似(3.85±1.67mm 比 3.81±1.93mm,p=0.64)。8 个月时,平均病变长度明显短于 POBA 组(5.78±3.26mm 比 6.97±4.59mm,p=0.04),但两组的平均节段内晚期丢失相似(0.28±0.45mm 比 0.27±0.38mm,p=0.75)。
在使用 DCB 治疗 ISR 病变时,NSE 和非顺应性球囊预扩张的 8 个月血管造影结果相似。然而,NSE 预扩张具有减少球囊滑脱和术中地理缺失等优点。